Brian Loeb has been with Conti since early 2016, having previously worked at J.P. Morgan within the Financial Institutions Investment Banking Group. At Conti, Brian has focused primarily on Conti Ventures, with a mandate to co-invest in early stage technology companies in the food, agriculture and restaurant sectors. Brian sits on the Board of Prenexus Health, Myco Technologies, Arzeda, Checkmate and Plasma Nutrition. Brian is a Board Observer at Brightseed Bio and Agot. He also helps manage Conti’s partnership with the Boulder Food Group, a VC fund focused on emerging CPG brands. Mr. Loeb holds a B.S. degree in Mechanical Engineering from Yale University.